In an era of pandemics optimising immunity is so important. However, so is the need to ensure we are implementing this through evidence-based solutions. Glutathione is renowned as the “master antioxidant” with impressive research backing its incredible ability to reduce oxidative stress, fight free radical damage and boost the utilisation and recycling of vitamin C and Vitamin E as well as CoQ10 and Alpha Lipoic acid. In addition, Glutathione is a powerful detoxifier and plays a major role in immune function. Not only does it protect against viruses, but it is also known to support the body against many ageing diseases such as heart disease, dementia, cancer, chronic fatigue syndrome, asthma, high cholesterol, and many other illnesses including skin disorders. Dr Stephanie Tan is the associate medical director of iXbiopharma and a clinical trial expert. In this lecture you will learn:
- Research updates on the role of glutathione in immunity
- How glutathione activates other antioxidants in the body
- Glutathione and skin health
- The most efficient delivery system of glutathione to the cells
About Dr Stephanie Tan
Dr Stephanie Tan is currently the Associate Medical Director at iX Biopharma. She obtained her medical degree from The University of Melbourne and practised full time for 11 years across a variety of disciplines before venturing into a clinical trials administrator/ managerial role. Her journey in clinical trials started as a co-investigator at the Skin and Cancer Foundation Victoria where she gained frontline trials experience through her direct involvement at every step of the study set-up to close-out. She left Melbourne in 2014 to pursue a regional leadership role at a multinational contract research organisation (IQVIA). At IQVIA, she was the regional medical advisor for global dermatology studies and the creator of a new business unit to service investigator-initiated trials. Stephanie returned to academia in 2016 and held concurrent appointments at Lee Kong Chian School of Medicine, National University Singapore’s Yong Loo Lin School of Medicine, National University Health System and National Healthcare Group. Her responsibilities include overseeing the service delivery of an early phase clinical trials unit, leading new initiatives in clinical trials education/training and providing strategic advice to leadership with an aim to improve the current clinical trial ecosystem in Singapore.
